Dendritic Cell Vaccination for Patients With Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Glioblastoma|Renal Cell Carcinoma|Sarcomas|Breast Cancers|Malignant Mesothelioma|Colorectal Tumors
Interventions: BIOLOGICAL: autologous dendritic cell vaccination
Sponsor: University Hospital, Antwerp